Open AccessHIV infection and glycemic response to newly initiated diabetic medical therapy
Author(s) -
Jennifer H. Han,
Heidi M. Crane,
Scarlett L. Bellamy,
Ian Frank,
Serena Cardillo,
Gregory P. Bisson
Publication year - 2012
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328359a8e5
Subject(s) - medicine , glycemic , regimen , diabetes mellitus , cohort , confidence interval , retrospective cohort study , cohort study , insulin , endocrinology
Type 2 diabetes (DM2) is increasingly common in HIV-infected individuals. Antiretroviral agents and chronic inflammation may adversely affect glycemic control. However, little is known about the effectiveness of diabetic medical therapy in HIV-infected patients. The objective of this study was to compare the effectiveness of initial diabetic medical therapy in patients with and without HIV infection.